Hereditary spastic paraparesis type 18 (SPG18): new ERLIN2 variants in a series of Italian patients, shedding light upon genetic and phenotypic variability

Introduction Hereditary spastic paraparesis (HSP) is a group of central nervous system diseases primarily affecting the spinal upper motor neurons, with different inheritance patterns and phenotypes.

SPG18 is a rare, early-onset, complicated HSP, first reported as linked to biallelic ERLIN2 mutations.

Recent cases of late-onset, pure HSP with monoallelic ERLIN2 variants prompt inquiries into the zygosity of such genetic conditions.

The observed relationship between phenotype and mode of inheritance suggests a potential dominant negative effect of mutated ERLIN2 protein, potentially resulting in a milder phenotype.

This speculation suggests that a wider range of HSP genes could be linked to various inheritance patterns.

Purpose and background With documented cases of HSP loci exhibiting both dominant and recessive patterns, this study emphasizes that the concept of zygosity is no longer a limiting factor in the establishment of molecular diagnoses for HSP.

Recent cases have demonstrated phenoconversion in SPG18, from HSP to an amyotrophic lateral sclerosis (ALS)-like syndrome.

Methods and results This report highlights two cases out of five exhibiting HSP-ALS phenoconversion, discussing an observed prevalence in autosomal dominant SPG18.

Additionally, the study emphasizes the relatively high incidence of the c.502G>A variant in monoallelic SPG18 cases.

This mutation appears to be particularly common in cases of HSPALS phenoconversion, indicating its potential role as a hotspot for a distinctive SPG18 phenotype with an ALS-like syndrome.

Conclusions Clinicians need to be aware that patients with HSP may show ALS signs and symptoms.

On the other hand, HSP panels must be included in genetic testing methods for instances of familial ALS.